BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the pricing of an underwritten public offering of 11,125,000 shares of its common stock at a public offering price of $24.00 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,375,000 shares of common stock at a public offering price of $23.9999 per pre-funded warrant, which represents the per share public offering price of each share of common stock less the $0.0001 per share exercise price for each pre-funded warrant. Monte Rosa also granted the underwriters a 30-day option to purchase up to an additional 1,875,000 shares of common stock at the public offering price,...

Miami, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) — Soren Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $253,000,000. The Company’s units began trading on January 7, 2026 on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “SORNU.” Each unit consists of one Class A ordinary share of the Company and one-third of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants...

SAN JOSE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — California Water Service Group (Group) (NYSE: CWT), the majority equity investor in BVRT Utility Holding Company LLC (BVRT) through its subsidiary, TWSC, Inc. (Texas Water), has entered into an agreement to purchase the remaining membership interests of BVRT and become the sole owner of its seven subsidiary water and wastewater utilities in the Austin-San Antonio corridor. At the same time, BVRT has continued to expand its Texas footprint through opportunities to build and enhance water and wastewater infrastructure in the area. Group expects to file a change of control application with the Public Utilities Commission of Texas (PUCT) soon to acquire the remaining BVRT membership interests. Texas Water’s acquisition of the remaining membership interests is subject to satisfaction...

Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year Facility NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue of US$35.1 million on Ryoncil® (remestemcel-L-rknd) sales for the quarter ended December 31, 2025.1 This represents a 60% increase on the prior quarter ended September 30, 2025. Ryoncil® is the first mesenchymal stromal cell (MSC) product approved by the U.S. Food and Drug Administration (FDA) for any indication. Ryoncil® is the only FDA-approved product approved for children under age 12 with steroid-refractory acute graft-versus-host disease (SR-aGvHD),2 and will now be evaluated in a pivotal trial as part of a second-line regimen for adults with SR-aGvHD, a market...

Taipei, Taiwan, Jan. 08, 2026 (GLOBE NEWSWIRE) — Semilux International Ltd. (the “Company”) received a letter (the “MVLS Deficiency Notice”) from the listing qualifications department staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that that from November 13, 2025 to December 30, 2025, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”). The MVLS Deficiency Notice has no immediate effect on the listing of the Company’s ordinary shares, and the Company’s common stock continues to trade on the Nasdaq Global Market under the symbol “SELX.” In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has 180 calendar days from...

Miami, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) — Lafayette Digital Acquisition Corp. I (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 25,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-fourth of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the Company’s initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share, subject to adjustments. The units are expected to trade on The Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “ZKPU” beginning January 9, 2026. No fractional warrants will be issued upon separation...

Trial to resolve all claims in the Anaptys and Tesaro/GSK dispute is scheduled for July 14-17, 2026SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, filed a partial motion to dismiss Tesaro’s anticipatory breach of contract claim in Delaware Chancery Court related to pending litigation between Anaptys, GSK, and TESARO, Inc. (“Tesaro”) regarding their Collaboration and Exclusive License Agreement (“Collaboration Agreement”), which entitles Anaptys to receive royalties upon sales of Jemperli. As previously disclosed, Anaptys approached Tesaro to engage in good faith discussions to potentially resolve Anaptys’ claims that Tesaro and GSK had breached the Collaboration Agreement. On Nov. 20, 2025, Tesaro, without...

DALLAS, Jan. 08, 2026 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the full year and fourth quarter of 2025 before market on Thursday, January 22, 2026. Executive management will host a conference call and webcast to discuss full year and fourth quarter 2025 operating results on Thursday, January 22, 2026, at 9:00 a.m. EDT. Participants may pre-register for the call by visiting https://www.netroadshow.com/events/login/LE9zwo3jjbLyj75pWUG0OhgKkHUzJIVWdRQ and will receive a unique PIN number to be used when dialing in for the call for immediate access. Alternatively, participants may call 833.470.1428 and use the access code 907780 at least fifteen minutes prior to the call to join through an operator. The...

TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) — Consolidated Lithium Metals Inc. (TSXV: CLM | FRA: Z36 | OTCQB: JORFF) (“CLM” or the “Company”) is pleased to announce that its common shares have commenced trading on the OTCQB® Venture Market, a U.S. trading platform operated by OTC Markets Group Inc. Effective January 8, 2026, CLM began trading under the symbol “JORFF.” Investors can access real-time quotes and market information at https://www.otcmarkets.com/stock/JORFF/overview. Richard Quesnel, President and CEO of CLM, stated: “We’re pleased to enhance visibility and access for our U.S. shareholders through this OTCQB® listing. It marks an important step in our plan to broaden our investor base.” The Company also announced today that it has granted an aggregate amount of 6,460,000 stock options to certain directors, officers and...

SAULT STE. MARIE, Ontario, Jan. 08, 2026 (GLOBE NEWSWIRE) — Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or “the Company”), a leading Canadian producer of hot and cold rolled steel sheet and plate products, today provided guidance for its quarter ended December 31, 2025. Unless otherwise specified, all amounts are in Canadian dollars. Total steel shipments for the quarter are expected to be in the range of 375,000 to 380,000 tons and Adjusted EBITDA is expected to be in the range of negative $95 million to negative $105 million. Rajat Marwah, Chief Executive Officer of Algoma, commented, “Our fourth-quarter results were in line with expectations, reflecting the continued impact of steel tariffs and the previously announced wind-down of our blast furnace operations, which are expected to conclude in the coming days....